MARSHALL WACE, LLP - ATARA BIOTHERAPEUTICS INC ownership

ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 125 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ATARA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$100,109
-65.5%
62,180
-18.8%
0.00%
-100.0%
Q3 2022$290,000
-73.5%
76,606
+0.4%
0.00%
-80.0%
Q1 2021$1,096,000
-91.2%
76,274
-87.9%
0.01%
-92.5%
Q4 2020$12,420,000
+248.9%
632,743
+130.4%
0.07%
+191.3%
Q3 2020$3,560,000
-68.3%
274,670
-64.4%
0.02%
-70.9%
Q2 2020$11,248,000
+1880.3%
771,966
+5295.3%
0.08%
+2533.3%
Q1 2019$568,00014,3080.00%
Other shareholders
ATARA BIOTHERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
BRIDGER MANAGEMENT, LLC 2,932,865$48,304,0003.48%
Camber Capital Management LP 2,950,000$48,587,0002.47%
Trellus Management Company, LLC 87,873$1,447,0002.42%
Redmile Group, LLC 4,648,570$76,562,0001.83%
Baupost Group 8,308,900$136,848,0001.51%
MAVERICK CAPITAL LTD 4,958,431$81,665,0001.19%
Artal Group S.A. 1,750,000$28,823,0001.11%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 175,000$2,882,0000.36%
12 West Capital Management LP 158,700$2,614,0000.16%
WASATCH ADVISORS LP 1,101,103$18,135,0000.15%
View complete list of ATARA BIOTHERAPEUTICS INC shareholders